<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
< Back to all Breaking News
TRVI
6/29/2022 07:06am
Trevi Therapeutics' Haduvio meets efficacy endpoint in Phase 2b/3 trial

dynamic_feed Breaking News